The lever they offer in return is a 30% off first month promo (code Shed10, auto-applied through this link) which softens the unknown
It is being smart
People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications
The clinical trials excluded participants on certain medications, so comprehensive interaction data is limited
Digestive symptoms are the most common side effects, but they are usually mild and can often be managed by gradually increasing the dose
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of drugs typically used to maintain glucose homeostasis in type 2 diabetes patients
